Close Menu

NEW YORK – Integrated DNA Technologies and Chinese medical sequencing firm ChosenMed are jointly developing large pan-cancer gene panels as part of the Cancer Genome Atlas of China (CGAC) project, IDT said today.

Under the strategic collaboration, IDT, a unit of Danaher, will provide its next-generation sequencing enrichment products for cancer sequencing to Beijing-based ChosenMed and help to enhance the firm's R&D capabilities.

Financial details of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.